Skip to main content

Table 5 Cox regression models to define predictors for incidental metabolic syndrome (according to AHA/NHLBI definition)

From: Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and disease activity

 

Model 1

Model 2

Model 3

Age

1.005, 0.98 to 1.03

1.009, 0.98 to 1.04

0.99, 0.98 to 1.02

BMI

1.14, 1.04 to 1.26

 

1.14, 1.04 to 1.25

BMI ≥25 kg/m2

 

3.07, 1.7 to 9.26

 

Cumulative DAS28

1.79, 1.33 to 2.43

1.92, 1.41 to 2.62

1.91, 1.37 to 2.68

Erosions at index date

  

0.71, 0.32 to 1.6

Follow-up

0.99, 0.97 to 1.004

0.99, 0.98 to 1.01

 
  1. Data presented as Exp (β), 95% confidence interval. AHA/NHLBI, American Heart Association/National Heart, Lung and Blood Institute; BMI, body mass index; DAS28, disease activity score evaluated in 28 joints.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us